|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash and cash equivalents | |||||||||||
| Marketable securities | |||||||||||
| Other assets | |||||||||||
| Property and equipment | |||||||||||
| Due from settlement of capital provision assets | |||||||||||
| Capital provision assets | |||||||||||
| Goodwill | |||||||||||
| Deferred tax asset | |||||||||||
| Total assets | |||||||||||
| Liabilities | |||||||||||
| Debt interest payable | |||||||||||
| Other liabilities | |||||||||||
| Long-term incentive compensation payable | |||||||||||
| Debt payable | |||||||||||
| Financial liabilities relating to third-party interests in capital provision assets | |||||||||||
| Deferred tax liability | |||||||||||
| Total liabilities | |||||||||||
| Shareholders' equity | |||||||||||
| Ordinary shares, no par value; unlimited shares authorized; 221,829,450 ordinary shares issued and 219,584,503 ordinary shares outstanding as of June 30, 2026 and 220,667,387 ordinary shares issued and 218,897,440 ordinary shares outstanding as of December 31, 2025 | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive income/(loss) | |||||||||||
| Treasury shares; 2,244,947 ordinary shares at $12.71 cost as of June 30, 2026 and 1,769,947 ordinary shares at $14.06 cost as of December 31, 2025 | |||||||||||
| Retained earnings | |||||||||||
| Total Burford Capital Limited equity | |||||||||||
| Non-controlling interests | |||||||||||
| Total shareholders' equity | |||||||||||
| Total liabilities and shareholders' equity | |||||||||||
| Ordinary shares outstanding (in shares) | |||||||||||
Loading...